These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 739695

  • 1. [Effects of vasoactive intestinal polypeptide (VIP) on histamine or prostaglandin F-2alpha-induced bronchoconstriction (author's transl)].
    Hara N, Yosida T, Said SI.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Dec; 16(11):840-5. PubMed ID: 739695
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of ipratropium bromide (Sch 1000) on the action of various bronchoactive agents (author's transl)].
    Ishihara Y, Izumi T, Hayashi R, Hsu LH, Sugiyama Y, Kitamura S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Aug; 18(8):501-5. PubMed ID: 6448308
    [No Abstract] [Full Text] [Related]

  • 3. Vasoactive intestinal polypeptide (VIP) inhibits prostaglandin-F2 alpha-induced activity of the rabbit myometrium.
    Ottesen B, Wagner G, Fahrenkrug J.
    Prostaglandins; 1980 Mar; 19(3):427-35. PubMed ID: 7384549
    [Abstract] [Full Text] [Related]

  • 4. Protease inhibitors potentiate smooth muscle relaxation induced by vasoactive intestinal peptide in isolated human bronchi.
    Tam EK, Franconi GM, Nadel JA, Caughey GH.
    Am J Respir Cell Mol Biol; 1990 May; 2(5):449-52. PubMed ID: 2187492
    [Abstract] [Full Text] [Related]

  • 5. [Experimental investigation on pathogenesis of paraben-induced asthma (author's transl)].
    Kitamura S, Ishihara Y, Kosaka K, Suetsugu S, Homma R, Umeda H.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1979 Apr; 17(4):244-9. PubMed ID: 480729
    [No Abstract] [Full Text] [Related]

  • 6. Actions of VIP, somatostatin, and pancreatic polypeptide on gallbladder tension and CCK-stimulated gallbladder contraction in vitro.
    Lonovics J, Devitt P, Rayford PL, Thompson JC.
    Surg Forum; 1979 Apr; 30():407-9. PubMed ID: 538649
    [No Abstract] [Full Text] [Related]

  • 7. Effect of vasoactive intestinal polypeptide on basal and cholecystokinin-induced gallbladder pressure.
    Ryan J, Cohen S.
    Gastroenterology; 1977 Oct; 73(4 Pt 1):870-2. PubMed ID: 892388
    [Abstract] [Full Text] [Related]

  • 8. [Effect of acetylcholine, bradykinin, and vasoactive intestinal polypeptide on the canine airways and pulmonary vascular bed (author's transl)].
    Sugiyama Y, Hsu LH, Ishihara Y, Kitamura S, Kosaka K.
    Kokyu To Junkan; 1982 Apr; 30(4):387-91. PubMed ID: 7100681
    [No Abstract] [Full Text] [Related]

  • 9. Vasoactive intestinal peptide and cholinergic neurotransmission in the ciliary muscle.
    Suzuki R, Kobayashi S.
    Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):250-3. PubMed ID: 6826329
    [Abstract] [Full Text] [Related]

  • 10. Vasoactive intestinal polypeptide (VIP): effect on rabbit uterine smooth muscle in vivo and in vitro.
    Ottesen B.
    Acta Physiol Scand; 1981 Oct; 113(2):193-9. PubMed ID: 6947684
    [Abstract] [Full Text] [Related]

  • 11. [Inhalation of a precursor analogue of vasoactive intestinal polypeptide (Leu17 VIP-Gly-Lys) protects ascaris-induced bronchoconstriction in dog].
    Hamada M, Uchida Y, Inoue M, Kameyama M, Nomura A, Ohtsuka M, Itoh O, Tachibana S, Hasegawa S.
    Arerugi; 1989 Dec; 38(12):1347-53. PubMed ID: 2634376
    [Abstract] [Full Text] [Related]

  • 12. Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part I: In vitro and in vivo bronchodilator studies.
    O'Donnell M, Garippa RJ, Rinaldi N, Selig WM, Simko B, Renzetti L, Tannu SA, Wasserman MA, Welton A, Bolin DR.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1282-8. PubMed ID: 7932180
    [Abstract] [Full Text] [Related]

  • 13. [Vasoactive intestinal polypeptide (VIP) (author's transl)].
    Kachelhoffer J, Marescaux J, Michel F, Grenier JF.
    Gastroenterol Clin Biol; 1979 Apr; 3(4):381-95. PubMed ID: 499699
    [No Abstract] [Full Text] [Related]

  • 14. [Regulation of gastrointestinal motility by gastrointestinal hormones (author's transl)].
    Takeuchi S, Ito S.
    Horumon To Rinsho; 1979 Apr; 27(12):1379-85. PubMed ID: 397014
    [No Abstract] [Full Text] [Related]

  • 15. Relaxant action of VIP on cat pulmonary artery: comparison with acetylcholine, isoproterenol, and PGE1.
    Hamasaki Y, Mojarad M, Said SI.
    J Appl Physiol Respir Environ Exerc Physiol; 1983 Jun; 54(6):1607-11. PubMed ID: 6874483
    [Abstract] [Full Text] [Related]

  • 16. Different mechanisms of action of vasoactive intestinal polypeptide (VIP) and glucagon on intestinal secretion.
    Mailman D.
    Gastroenterology; 1977 Dec; 73(6):1463-5. PubMed ID: 913990
    [No Abstract] [Full Text] [Related]

  • 17. Vasodilatory effects of vasoactive intestinal polypeptide (VIP) on isolated rat arteries.
    Suzuki Y, Kobayashi Y, Lederis K.
    Proc West Pharmacol Soc; 1983 Dec; 26():341-4. PubMed ID: 6889362
    [No Abstract] [Full Text] [Related]

  • 18. [The effect of VIP on cyclic nucleotides contents of guinea-pig lung and tracheal tissues (author's transl)].
    Kitamura S, Ishihara Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Jun; 15(6):205-300. PubMed ID: 198597
    [No Abstract] [Full Text] [Related]

  • 19. Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret.
    Franconi GM, Graf PD, Lazarus SC, Nadel JA, Caughey GH.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):947-51. PubMed ID: 2495355
    [Abstract] [Full Text] [Related]

  • 20. Synergistic effect of nitric oxide and vasoactive intestinal peptide on bronchoprotection against histamine in anesthetized guinea pigs.
    Kanazawa H, Kawaguchi T, Shoji S, Fujii T, Kudoh S, Hirata K, Kurihara N, Yoshikawa J.
    Am J Respir Crit Care Med; 1997 Feb; 155(2):747-50. PubMed ID: 9032223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.